These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 29633623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
    Zheng Y, Ma H, Hu E, Huang Z, Cheng X, Xiong C.
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):504-14. PubMed ID: 26535780
    [Abstract] [Full Text] [Related]

  • 3. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
    Leong ZP, Okida A, Higuchi M, Yamano Y, Hikasa Y.
    Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X, Yang Y, Yang D, Tong G, Lv S, Lin X, Chen C, Dong W.
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [Abstract] [Full Text] [Related]

  • 6. Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats.
    Wang HM, Wang Y, Liu M, Bai Y, Zhang XH, Sun YX, Wang HL.
    Can J Physiol Pharmacol; 2012 Nov; 90(11):1506-15. PubMed ID: 23181278
    [Abstract] [Full Text] [Related]

  • 7. Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
    Markvardsen LK, Sønderskov LD, Wandall-Frostholm C, Pinilla E, Prat-Duran J, Aalling M, Mogensen S, Andersen CU, Simonsen U.
    J Vasc Res; 2021 Nov; 58(4):237-251. PubMed ID: 33910208
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of ubiquitin proteasome function prevents monocrotaline-induced pulmonary arterial remodeling.
    Zhu Y, Wu Y, Shi W, Wang J, Yan X, Wang Q, Liu Y, Yang L, Gao L, Li M.
    Life Sci; 2017 Mar 15; 173():36-42. PubMed ID: 28212825
    [Abstract] [Full Text] [Related]

  • 9. C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Zopf DA, das Neves LA, Nikula KJ, Huang J, Senese PB, Gralinski MR.
    Eur J Pharmacol; 2011 Nov 16; 670(1):195-203. PubMed ID: 21914448
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
    Leong ZP, Hikasa Y.
    Vascul Pharmacol; 2018 Nov 16; 110():31-41. PubMed ID: 30071297
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Magnolol ameliorates pneumonectomy and monocrotaline-induced pulmonary arterial hypertension in rats through inhibition of angiotensin II and endothelin-1 expression.
    Chang H, Chang CY, Lee HJ, Chou CY, Chou TC.
    Phytomedicine; 2018 Dec 01; 51():205-213. PubMed ID: 30466619
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
    Yang JM, Zhou R, Zhang M, Tan HR, Yu JQ.
    Molecules; 2018 May 26; 23(6):. PubMed ID: 29861433
    [Abstract] [Full Text] [Related]

  • 17. Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Han DD, Wang Y, Zhang XH, Liu JR, Wang HL.
    Can J Physiol Pharmacol; 2012 Apr 26; 90(4):445-54. PubMed ID: 22448962
    [Abstract] [Full Text] [Related]

  • 18. 5-Aminosalicylic Acid Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Increasing the Expression of Nur77.
    Sun LY, Cai ZY, Pu J, Li J, Shen JY, Yang CD, He B.
    Inflammation; 2017 Jun 26; 40(3):806-817. PubMed ID: 28213866
    [Abstract] [Full Text] [Related]

  • 19. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
    Lee JH, Park BK, Oh KS, Yi KY, Lim CJ, Seo HW, Lee BH.
    Int Immunopharmacol; 2016 Nov 26; 40():196-202. PubMed ID: 27611861
    [Abstract] [Full Text] [Related]

  • 20. Effects of atorvastatin and losartan on monocrotaline-induced pulmonary artery remodeling in rats.
    Xie L, Lin P, Xie H, Xu C.
    Clin Exp Hypertens; 2010 Nov 26; 32(8):547-54. PubMed ID: 21091363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.